NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-043-2011-0-IE-24 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines IE EP 11849865.8 Abandoned
NIAID E-043-2011-0-BE-17 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines BE EP 11849865.8 Abandoned
NIAID E-043-2011-0-GB-23 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines GB EP 11849865.8 Issued
NIAID E-043-2011-0-SE-28 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines SE EP 11849865.8 Abandoned
NIAID E-043-2011-0-ES-21 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines ES EP 11849865.8 Issued
NIAID E-043-2011-0-CH-18 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines CH EP 11849865.8 Abandoned
NIAID E-043-2011-0-EP-14 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines EP National Stage 11849865.8 Issued
NIAID E-043-2011-0-EA-13 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines EA National Stage 201390866 Abandoned
NIAID E-043-2011-0-AP-12 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines AP National Stage AP/P/2013/006972 Abandoned
NIAID E-043-2011-0-JP-08 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines JP National Stage 2013-544747 Issued
NIAID E-043-2011-0-AU-03 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines AU National Stage 2011343798 Abandoned
NIAID E-043-2011-0-CN-06 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines CN National Stage 201180067429.7 Issued
NCI E-021-2011-0-PCT-02 Synthetic Peptide Inhibitors Of WNT Pathway PCT PCT PCT/US2011/064902 Expired
NCI E-021-2011-0-EP-04 Synthetic Peptide Inhibitors Of WNT Pathway EP National Stage 11806070.6 Abandoned
NIAID E-043-2011-0-PCT-02 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines PCT PCT PCT/US2011/064944 Expired
NIAID E-240-2012-0-US-01 CD-4 Mimetic Inhibitors Of HIV Entry And Methods Of Use Thereof US 61/570,536 Abandoned
NIEHS E-130-2004-0-US-07 METHODS RELATED TO THE TREATMENT OF NEURODEGENERATIVE AND INFLAMMATORY CONDITIONS US CON 13/324,876 8796302 Expired PDF
NCI E-018-2011-0-PCT-02 Methods For Decreasing Body Weight And Treating Diabetes PCT PCT PCT/US2011/064690 Expired
NCI E-063-2003-0-US-06 Rapamycin-Resistant T Cells and Therapeutic Uses Thereof US CON 13/323,323 Abandoned
NIDDK E-234-2011-1-US-01 Conjugating Amines US 61/569,632 Abandoned
NIAID E-043-2011-0-AO-15 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines AO National Stage 2491-02-23 Abandoned
NCI E-181-2012-0-US-01 TumIor-Specific GM-CSF Cytokine Response as Predictor of Cancer Vaccine Effectiveness US 61/569,131 Abandoned
NCATS E-257-2010-0-BR-09 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators BR National Stage BR1120130142421 Issued
NCATS E-257-2010-0-IN-11 SUBSTITUTED PYRAZOLOPYRIMIDINES, DIHYDROPYRAZOLOPYRIMIDINES AND RELATED COMPOUNDS, AND PHARMACEUTICAL COMPOSITIONS IN National Stage 5102/DELNP/2013 Issued
NCATS E-257-2010-0-KR-12 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators KR National Stage 10-2013-7017520 Issued
NCATS E-257-2010-0-NL-37 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators NL EP 11810714.3 Issued
NCATS E-257-2010-0-PL-39 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators PL EP 11810714.3 Issued
NCATS E-257-2010-0-SI-44 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators SI EP 11810714.3 Issued
NCATS E-257-2010-0-SK-42 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators SK EP 11810714.3 Issued
NCATS E-257-2010-0-NO-38 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators NO EP 11810714.3 Issued
NCATS E-257-2010-0-PT-40 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators PT EP 11810714.3 Issued
NCATS E-257-2010-0-IE-33 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IE EP 11810714.3 Issued
NCATS E-257-2010-0-IT-35 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IT EP 11810714.3 Issued
NCATS E-257-2010-0-IS-34 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IS EP 11810714.3 Issued
NCATS E-257-2010-0-GR-31 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators GR EP 11810714.3 Issued
NCATS E-257-2010-0-HU-32 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators HU EP 11810714.3 Issued
NCATS E-257-2010-0-ES-28 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators ES EP 11810714.3 Issued
NCATS E-257-2010-0-CH-24 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators CH EP 11810714.3 Issued
NCATS E-257-2010-0-GB-30 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators GB EP 11810714.3 Issued
NCATS E-257-2010-0-SE-41 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators SE EP 11810714.3 Issued
NCATS E-257-2010-0-TR-43 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators TR EP 11810714.3 Issued
NCATS E-257-2010-0-BE-23 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators BE EP 11810714.3 Issued
NCATS E-257-2010-0-AT-22 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators AT EP 11810714.3 Issued
NCATS E-257-2010-0-DE-25 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators DE EP 11810714.3 Issued
NCATS E-257-2010-0-FR-29 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators FR EP 11810714.3 Issued
NCATS E-257-2010-0-DK-26 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators DK EP 11810714.3 Issued
NCATS E-257-2010-0-EE-27 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators EE EP 11810714.3 Issued
NCATS E-257-2010-0-LU-36 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators LU EP 11810714.3 Issued
NCATS E-257-2010-0-EP-05 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators EP National Stage 11810714.3 Issued
NCATS E-257-2010-0-MX-13 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators MX National Stage MX/a/2013/006462 Issued